Zynex Financials

ZYXI Stock  USD 8.11  0.25  3.18%   
Based on the key measurements obtained from Zynex's financial statements, Zynex Inc is performing exceptionally good at this time. It has a great probability to report excellent financial results in December. As of now, Zynex's Other Current Assets are increasing as compared to previous years. The Zynex's current Total Current Assets is estimated to increase to about 92.2 M, while Common Stock Shares Outstanding is projected to decrease to under 30.4 M. Key indicators impacting Zynex's financial strength include:
Current ValueLast YearChange From Last Year 10 Year Trend
Current Ratio4.984.7407
Sufficiently Up
Slightly volatile
Investors should never underestimate Zynex's ability to pay suppliers on time, ensure interest payments are not accumulating, and correctly time where and how to reinvest extra cash. Individual investors need to monitor Zynex's cash flow, debt, and profitability to make informed and accurate decisions about investing in Zynex Inc.

Net Income

10.22 Million

  
Understanding current and past Zynex Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Zynex's financial statements are interrelated, with each one affecting the others. For example, an increase in Zynex's assets may result in an increase in income on the income statement.

Zynex Stock Summary

Zynex competes with Henry Schein, Owens Minor, Cardinal Health, Patterson Companies, and McKesson. Zynex, Inc., through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain and activate and exercise muscles for rehabilitative purposes with electrical stimulation. Zynex, Inc. was founded in 1996 and is headquartered in Englewood, Colorado. Zynex operates under Medical Distribution classification in the United States and is traded on NASDAQ Exchange. It employs 774 people.
Specialization
Health Care, Health Care Equipment & Services
InstrumentUSA Stock View All
ExchangeNASDAQ Exchange
ISINUS98986M1036
CUSIP98986M103
LocationColorado; U.S.A
Business Address9655 Maroon Circle,
SectorHealth Care Equipment & Supplies
IndustryHealth Care
BenchmarkDow Jones Industrial
Websitewww.zynex.com
Phone303 703 4906
CurrencyUSD - US Dollar

Zynex Key Financial Ratios

Zynex Key Balance Sheet Accounts

201920202021202220232024 (projected)
Total Assets28.3M72.2M133.3M116.5M136.9M143.7M
Retained Earnings14.4M23.4M0.017.0M26.8M28.1M
Other Current Assets315K2.8M1.4M868K3.3M3.5M
Total Current Assets22.6M63.0M82.7M69.6M87.9M92.2M
Total Liab8.6M15.3M59.3M50.1M90.8M95.3M
Other Current Liab1.8M864K4.5M5.5M1.6M1.9M
Net Debt(9.4M)(31.8M)(7.5M)6.8M31.6M33.2M
Accounts Payable2.1M4.7M4.7M5.6M8.4M8.9M
Net Receivables5.8M13.8M28.6M35.1M26.8M28.2M
Inventory2.4M8.6M10.8M13.5M13.1M13.8M
Short Term Debt1.3M4.3M11.3M7.9M7.9M8.2M
Cash14.0M39.2M42.6M20.1M44.6M46.8M
Other Assets842K913K1.3M2.2M1.00.95
Net Tangible Assets19.7M56.9M43.5M36.9M42.4M44.5M
Capital Surpluse9.2M37.2M80.4M82.4M94.8M99.5M

Zynex Key Income Statement Accounts

201920202021202220232024 (projected)
Interest Expense5K19K95K440K1.1M1.1M
Total Revenue45.5M80.1M130.3M158.2M184.3M193.5M
Gross Profit36.7M62.7M103.0M126.2M146.0M153.3M
Operating Income11.1M10.2M22.4M22.9M10.8M11.3M
Ebit11.1M10.2M22.4M22.9M10.8M11.3M
Ebitda11.8M11.7M24.7M26.1M15M15.8M
Cost Of Revenue8.8M17.4M27.3M32.0M38.4M40.3M
Income Before Tax11.9M10.2M22.3M22.2M12.6M13.2M
Net Income9.5M9.1M17.1M17.0M9.7M10.2M
Income Tax Expense2.4M1.1M5.2M5.2M2.8M3.0M
Research Development600K800K2.6M7.1M9.2M9.7M
Tax Provision2.4M1.1M5.2M5.2M4.4M2.3M
Net Interest Income(5K)(19K)(95K)(440K)(823K)(864.2K)

Zynex Key Cash Accounts

201920202021202220232024 (projected)
Change To Inventory(2.4M)(7.3M)(3.8M)(4.3M)(1.4M)(1.5M)
Change In Cash3.9M25.1M3.4M(22.5M)24.4M25.7M
Free Cash Flow6.1M(167K)6.3M13.3M16.6M17.4M
Depreciation778K1.6M2.3M3.1M4.2M4.4M
Other Non Cash Items(695K)(236K)1.3M1.2M(2.1M)(2.0M)
Capital Expenditures160K985K609K418K1.2M1.3M
Net Income9.5M9.1M17.1M17.0M9.7M10.2M
End Period Cash Flow14.0M39.2M42.6M20.1M44.6M46.8M
Change To Netincome1.2M2.6M1.5M1.8M2.1M1.3M
Change Receivables(3.0M)(8.0M)(14.8M)(6.4M)(5.8M)(5.5M)
Net Borrowings(19K)(57K)16.0M(5.3M)(6.1M)(5.8M)
Investments(160K)(985K)(16.6M)(418K)(10.5M)(10.0M)

Zynex Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Zynex's current stock value. Our valuation model uses many indicators to compare Zynex value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Zynex competition to find correlations between indicators driving Zynex's intrinsic value. More Info.
Zynex Inc is rated third in return on equity category among its peers. It is rated third in return on asset category among its peers reporting about  0.39  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Zynex Inc is roughly  2.56 . As of now, Zynex's Return On Equity is decreasing as compared to previous years. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Zynex's earnings, one of the primary drivers of an investment's value.

Zynex Inc Systematic Risk

Zynex's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Zynex volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Beta measures systematic risk based on how returns on Zynex Inc correlated with the market. If Beta is less than 0 Zynex generally moves in the opposite direction as compared to the market. If Zynex Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Zynex Inc is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Zynex is generally in the same direction as the market. If Beta > 1 Zynex moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in Zynex Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Zynex's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Zynex growth as a starting point in their analysis.

Price Earnings To Growth Ratio

(0.98)

As of now, Zynex's Price Earnings To Growth Ratio is decreasing as compared to previous years.

Zynex November 22, 2024 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Zynex help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Zynex Inc. We use our internally-developed statistical techniques to arrive at the intrinsic value of Zynex Inc based on widely used predictive technical indicators. In general, we focus on analyzing Zynex Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Zynex's daily price indicators and compare them against related drivers.

Complementary Tools for Zynex Stock analysis

When running Zynex's price analysis, check to measure Zynex's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Zynex is operating at the current time. Most of Zynex's value examination focuses on studying past and present price action to predict the probability of Zynex's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Zynex's price. Additionally, you may evaluate how the addition of Zynex to your portfolios can decrease your overall portfolio volatility.
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Technical Analysis
Check basic technical indicators and analysis based on most latest market data